TipRanks
Aktis Oncology, Inc. (AKTS)
NASDAQ:AKTS
US Market
AKTS
Aktis Oncology, Inc.
RESEARCH TOOLSreports
Want to see AKTS full AI Analyst Report?

Aktis Oncology, Inc. (AKTS) Income Statement

42 Followers

Aktis Oncology, Inc. Income Statement

Last quarter (Q2 2026), Aktis Oncology, Inc.'s total revenue was $3.38M, an increase of 262.70% from the same quarter last year. In Q2, Aktis Oncology, Inc.'s net income was $-24.14M. See Aktis Oncology, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 6.50M$ 1.49M$ 0.00$ 0.00
Gross Profit
$ 6.50M$ 1.49M$ 0.00$ 0.00
Operating Expenses
$ 81.18M$ 53.54M$ 34.79M$ 19.76M
Depreciation and Amortization
$ 2.33M$ 1.57M$ 1.20M$ 445.00K
EBITDA
$ -61.40M$ -42.41M$ -27.45M$ -17.48M
Operating Income
$ -74.68M$ -52.05M$ -34.79M$ -19.76M
Other Income/Expenses
$ 10.95M$ 8.07M$ 6.15M$ 1.83M
Pretax Income
$ -63.73M$ -43.98M$ -28.64M$ -17.93M
Net Income
$ -63.73M$ -43.98M$ -28.64M$ -17.93M
Per Share Metrics
Basic EPS
$ -1.19$ -1.26$ -0.82$ -0.51
Diluted EPS
$ -1.19$ -1.26$ -0.82$ -0.51
Weighted Average Shares Outstanding
 52.52M 34.86M 34.86M 34.86M
Weighted Average Shares Outstanding (Diluted)
 52.52M 34.86M 34.86M 34.86M
Currency in USD

Aktis Oncology, Inc. Earnings and Revenue History